HeraMED Limited (FRA:1I4)

Germany flag Germany · Delayed Price · Currency is EUR
0.0225
-0.0010 (-4.26%)
At close: Dec 4, 2025
95.65%
Market Cap 21.39M
Revenue (ttm) 180.28K
Net Income (ttm) -2.53M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 100,000
Average Volume 87,862
Open 0.0225
Previous Close 0.0235
Day's Range 0.0225 - 0.0225
52-Week Range 0.0035 - 0.0535
Beta n/a
RSI 50.06
Earnings Date Nov 28, 2025

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant moth... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2011
Country Australia
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1I4
Full Company Profile

Financial Performance

In 2024, HeraMED's revenue was 364,328, a decrease of -39.90% compared to the previous year's 606,226. Losses were -5.49 million, -18.96% less than in 2023.

Financial numbers in AUD Financial Statements

News

There is no news available yet.